The pooled ORs of 12 variants in 8 genes (CTLA-4, ERCC3, IL-8, PRCKG, RECQL5, TNF-α, XRCC3, and VEGF) were significantly associated with the risk of osteosarcoma in the main analysis. This evidence concerns the gene RECQL5 and osteosarcoma.